TMI's Embedded Staff Model Maximizes the Benefits from
Leveraging India for Your Clinical Trials

Rapid Patient Accrual
More Sophisticated POC Studies
World Class Quality

Speed - Quality - Innovation

Translational Medicine India (TMI) is U.S. headquartered clinical CRO that specializes in conducting Pivotal Trials and Proof of Concept Studies (Phase 2-3 clinical trials) in India – all to the highest global standards. TMI also provides a range of other clinical studies services in India through its India organization.

Our “Embedded Staff Model” enables us to achieve best in class patient accrual across a broad range of trial types, the absolute highest level of quality found anywhere in the world, and the capability to conduct highly sophisticated POC studies. Because of advantages unique to India, this speed, quality, and flexibility is all provided at substantially lower cost to sponsors.

“TMI has an impressive track record of helping clients achieve their goals on pivotal trials – TMI managed sites are often the best performing globally.”

We work with sponsors across a broad range of disease domains including Oncology, Gastroenterology, Autoimmune, Neurodegenerative, Lifestyle, and ophthalmology.